Evaluation of opportunities for the use of modern methods for correction and prevention of risks in the quality control of clinical trials

Journal Title: ScienceRise: Pharmaceutical Science - Year 2018, Vol 0, Issue 5

Abstract

To organize and conduct a clinical trial (СT) at a high level, it is necessary to continuously monitor its quality, as the occurrence of non-conformances can threaten health and safety of the trial subjects, as well as lead to CT data loss or their unreliability. In general, for the effective CT quality control, it is expedient to continuously improve the quality management system of all parties who participate in the CT, including at the clinical site. Current regulatory requirements include an indication of the need for a continuous process of the quality management system improvement to ensure the proper level of the process performance, in particular, the system of non-conformances correction and prevention. The aim of this work was to evaluate the possibilities and problems of applying modern methods of risks correction and prevention in the CT quality management. Materials and methods. To achieve the aim of the study, a meta-analysis of literature sources using PICO search technology was carried out and analysis of existing regulatory documents on the availability of methodologies, instructions and algorithms for selecting and applying the non-conformances correction and prevention tools during CT organizing and conducting. Results of the study. The study showed that regulatory authorities see the need for standardized CT quality management systems to increase the number of qualified clinical sites, as well as more strict compliance with the ICH GCP principles. The analysis of regulatory documents showed the absence of unified harmonized requirements for carrying out the processes of correction and prevention of non-conformances within the framework of CT organizing and conducting. Conclusions.Organizing and conducting of CT requires continuous monitoring of the quality of the processes carried out to ensure getting of complete and reliable data on the study drug. Given the lack of regulatory requirements governing the process of non-conformances correction and prevention, it seems expedient to develop an algorithm for work with CAPA-plan and its methodology, as well as SOP to standardize the conduct of this process

Authors and Affiliations

Tetyana Kolodyezna, Kateryna Zupanets, Victoria Dobrova

Keywords

Related Articles

Аналіз засобів та особливостей розробки курсу з навчальної дисципліни для системи дистанційної освіти

<p>У даній статті досліджуються особливості дистанційної освіти, зокрема, у фармацевтичному ВНЗ. Розглянуті тенденції впровадження у процес навчання сучасних інформаційних технологій.</p><p><strong>Методи.</strong> У ход...

Визначення агомелатину у сечі в присутності метаболітів методом газової хроматографії із мас-спектрометричним детектуванням (ГХ-МС)

<p><strong>Мета дослідження: </strong>розробка та валідація методики кількісного визначення агомелатину в сечі в присутності його метаболітів за допомогою ГХ-МС.</p><p><strong>Методи:</strong> Для виділення агомелатину і...

Selection of flavoring agents and primary packaging for the combined oral solution named «Maglycimet»

<p><strong>Aim.</strong> The main aim of research is selection of flavoring agents and primary packaging for a combined oral solution named «Maglycimet» based on theoretical and experimental. The solution consists of mag...

Antipyretic activity of the new 2-(((3-mercapto-5-methyl-4н-1,2,4-triazol-4-yl)imino)methyl)-5-r-benzoates

Temperature rise is an important defensive mechanism of the body that activates immune system and increases phagocytosis, suppressing viral and microbial growth. Antipyretic activity, which involves the increase of therm...

The analysis of the sale of antihypertensive drugs in the pharmacies of Kyiv

<p><strong>А</strong><strong>im.</strong> Antihypertensive drugs (AHD) belong to the category of the most commonly used drugs in the pharmaceutical market of Ukraine. This is due to the significant prevalence of arterial...

Download PDF file
  • EP ID EP647917
  • DOI 10.15587/2519-4852.2018.145593
  • Views 139
  • Downloads 0

How To Cite

Tetyana Kolodyezna, Kateryna Zupanets, Victoria Dobrova (2018). Evaluation of opportunities for the use of modern methods for correction and prevention of risks in the quality control of clinical trials. ScienceRise: Pharmaceutical Science, 0(5), 10-16. https://europub.co.uk/articles/-A-647917